Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > 8 trading days left until Q1 financials
View:
Post by LithLover on May 05, 2021 4:54pm

8 trading days left until Q1 financials

Tripp said revenue was on a "trajectory" so expecting some good numbers to be reported soon.  

Q3  $1,46 million

Q4 $2.82 million

Q1  ??? (May 17) Jan-March

Q2 ??? (Aug 16) - April-June start of Care Oncology Aristotle testing (April)  and Rexall deal (May)


Should continue to see very solid revenue growth for months to come.
Comment by Mykndrsn on May 05, 2021 6:48pm
This post has been removed in accordance with Community Policy
Comment by Liked2Think on May 05, 2021 9:47pm
I will be labelled as a basher again but I think you are expecting it too soon Covid revenue from Rexal just starting in May with a rollout.  Wont start really rolling to June.  Still good though. Just in time for summer travels. I dont think there will be an Aristotle test by Care until July though.  I hope Im wrong but I am not going to assume it will happen before then.  ...more  
Comment by LithLover on May 05, 2021 10:16pm
Not a basher.  In fact I agree with you.   I merely noted that the quarters when we started those deals it could come in later in the year but the point is the revenue will continue to grow. All to help fund Aristotle marketing and more deals    I am expecting 4-5 million in Q1  people will take notice   And the btv will help start    We will see more ...more  
Comment by Liked2Think on May 06, 2021 1:07am
If there is 5M in Q1 then thats huge.  I would be happy with a 4 and a low 4 but I think there needs to be a 4 at least.  Just blow past 3 all together. covid testing for travel is obvioulsy going to be the longest term for testing.  I suspect we could get a few years of that being required and then have it tapper off to select countries for awhile
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities